Catalyst Wire Dossier Catalyst Wire Dossier
EMA guidance · 2024-01-12

Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 8-11 January 2024

View source ↗

Summary

PRAC highlights potential risk of neurodevelopmental disorders in children born to men treated with valproate medicines and recommends precautionary measures.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • valproate medicines (valproate)

Snippet

Potential risk of neurodevelopmental disorders in children born to men treated with valproate medicines: PRAC recommends precautionary measures